Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. حسب Masashi Okawa (8951294)

الموضوعات:

The characteristics and clinical features of 12 patients. حسب Masashi Okawa (8951294)

الموضوعات:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. حسب Masashi Okawa (8951294)

الموضوعات:

Exploring the correlation between systemic inflammation biomarkers and HCV infection (logarithm base 2). حسب Lu Han (151620)

الموضوعات:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. حسب Masashi Okawa (8951294)

الموضوعات:

Threshold effect analysis of systemic inflammatory biomarkers on hepatitis C using two-piece wise linear regression. حسب Lu Han (151620)

الموضوعات:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. حسب Masashi Okawa (8951294)

الموضوعات:

The original data for the figures. حسب Masashi Okawa (8951294)

الموضوعات:

Exclusion and enrollment summary from NHANES. حسب Lu Han (151620)

الموضوعات:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات:

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. حسب Masashi Okawa (8951294)

الموضوعات:

Demographic information and baseline population characteristics. حسب Lu Han (151620)

الموضوعات:

Stratified associations between systemic inflammation biomarkers and hepatitis C (OR 95%, <i>P</i> value, LOG base 2). حسب Lu Han (151620)

الموضوعات:

General addictive models demonstrate the relationship between systemic inflammatory biomarkers and anti-HCV. حسب Lu Han (151620)

الموضوعات:

Comparison of systemic inflammation biomarkers in infected and uninfected populations. حسب Lu Han (151620)

الموضوعات:

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات:

Hypothetical mechanism by which plasma VEGF-A121 concentration is elevated post-bevacizumab administration. حسب Masashi Okawa (8951294)

الموضوعات:

Flow chart of data screening and analysis. حسب Yan She (8639796)

"…In contrast, BALP was significantly lower in the 9-week and 12-week model groups compared to levels in the sham operation group, while the levels of TRACP-5b in the 9-week and 12-week model groups were significantly higher than those in the sham operation group(P < 0.001).…"

Serum phosphorus level. حسب Naoki Suzuki (308620)

"…Serum phosphorus levels were decreased in both groups, with comparable control. …"

Serum albumin level. حسب Naoki Suzuki (308620)

"…Serum phosphorus levels were decreased in both groups, with comparable control. …"